Single-crystal – oriented-crystal – and epitaxy growth processes; – Processes of growth with a subsequent step acting on the...
Reexamination Certificate
2005-10-18
2005-10-18
Kunemund, Robert (Department: 1722)
Single-crystal, oriented-crystal, and epitaxy growth processes;
Processes of growth with a subsequent step acting on the...
C117S925000, C117S926000, C117S927000, C424S133100, C424S136100, C435S070210, C530S387700, C530S388100, C530S388750, C530S388850
Reexamination Certificate
active
06955717
ABSTRACT:
The present invention provides machine readable media embedded with the three-dimensional atomic structure coordinates of Synagis Fab, and subsets thereof, and methods of using them.
REFERENCES:
patent: 5994511 (1999-11-01), Lowman et al.
patent: 6113898 (2000-09-01), Anderson et al.
patent: 6129914 (2000-10-01), Weiner et al.
patent: WO 96/40252 (1996-12-01), None
patent: WO 00/61618 (2000-10-01), None
patent: PCT/US 02/13583 (2003-04-01), None
Hampton Research , “Crystal Screen Users Guide,” (1991).
Johnson et al., “Development of a Humanized Monoclonal Antibody (MEDI-493) With Potent In Vitro and In Vivo Activity Against Respiratory Syncytial Virus,” The Journal of Infectious Diseases (1997) 176:1215-24.
Meissner et al., “Immunoprophylaxis With Palivizumab, A Humanized Respiratory Syncytial Virus Monoclonal Antibody, For Prevention of Respiratory Syncytial Virus Infection In High Risk Infants: A Consensus Opinion,” Pediatr Infect Dis. J, (1999) 18:223-31.
Braden Bradford
Johnson Leslie S.
Bowie State University
Jones Day
Kunemund Robert
Medimmune Inc.
LandOfFree
Crystals and structure of Synagis Fab does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystals and structure of Synagis Fab, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystals and structure of Synagis Fab will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3441256